Regenon retard 60mg is used for the treatment of exogenous obesity, associated with a hypocaloric diet and exercise regime.
1 capsule Regenon retard 60 mg contains: amfepramone hydrochloride 60 mg.
excipients: neutral microgranules, schellack, ethyl cellulose, tartaric acid, povidone, talc, highly dispersed silicon dioxide, gelatin, indigo carmine, erythrozine titanium dioxide
Note: Weight reduction has been shown to be short-term in the absence of an appropriate diet afterwards. Data are still insufficient to indicate a change in morbidity or mortality.
When Regenon Retard 60 mg is not allowed?
Regenon Delay 60 mg will not be used in the following cases:
– known hypersensitivity to any of the components
– tachycardic arrhythmias – pheochromocytoma
– severe forms of angina pectoris
– narrow-angle glaucoma
– pulmonary hypertension
– severe hypertension
– history or cardiovascular or cerebrovascular
– history or psychiatric disorders, including anorexia nervosa and depression
– a tendency to drug abuse, drug addiction or alcohol
– advanced atherosclerosis
– children under 12 years old
Regenon retard 60mg is contraindicated to associate this treatment with any other centrally active anorexic product because of the risk of life-threatening pulmonary hypertension.
Dosage Regenon retard 60mg
Before prescribing Regenon retard 60mg , the diagnosis of obesity due to secondary organic causes should be excluded.
The treatment of obesity must be carried out according to a global approach which must include dietary, medical and psychotherapeutic methods.
Adults and children over 12 years. One capsule of Regenon delay 60 mg daily.
The total daily dose should not exceed one 60 mg Regenon Retard Sustained Release capsule.
Regenon Retard capsules should be swallowed whole with some liquid before main meals.
The last dose should be given at least 4 hours before bedtime, which causes agitation and insomnia.
It is recommended to administer the treatment under the supervision of a doctor experienced in the treatment of obesity.
Duration of treatment Regenon retard 60mg
The duration of treatment is 4 to 6 weeks and should not exceed three months.
If no weight loss is seen after 3-4 weeks, treatment should be discontinued. If treatment is longer than 4 weeks, the benefit should be carefully weighed against the potential risk. Even in the event of weight loss, Regenon Delay should not be taken for more than 12 weeks.
Interaction with other drugs
What other medicines influence the use of Regenon Retard 60 mg?
The action of Regenon Retard 60 mg may be potentially compromised by concomitant administration of adrenergic amines, antidepressants, amantadine and MAO inhibitors. This is true for MAO inhibitors even within two weeks of stopping treatment.
The central stimulating action as well as the appetite suppressing effect are totally or partially eliminated by the concomitant administration of neuroleptics such as phenothiazines and butyrophenones.
The effect of the action of the product is not completely excluded as an increase in the risk of abuse due to concomitant administration of high doses of caffeine (coffee, cola drinks).
Serious cases of pulmonary hypertension, often fatal, have been reported in patients receiving such anorexia. An epidemiological study has shown that anorexigenic administration is a risk factor for the development of pulmonary arterial hypertension and that its administration is closely related to the increased risk of adverse effects of this type of medication. Because of this rare but serious risk, we draw attention to the fact that:
– Careful individualization of the indications and the
Duration of treatment is required – A treatment duration of more than 3 months and a BMI of 30 kg / m2 or more increase the risk of pulmonary hypertension.
– The appearance or worsening of dyspnea suggests the possibility of pulmonary hypertension. in this case, the treatment must be stopped immediately and the patient sent to a specialized unit for investigation.